pregabalin and Genital-Neoplasms--Female

The aim of this study was to identify predictors for paclitaxel-induced peripheral neuropathy (PIPN).. We conducted a retrospective analysis of 227 patients who had been treated with paclitaxel at a single institution between January 2008 and July 2011. At the time of chemotherapy completion, the severity of PIPN was graded on a scale of 0-5, in accordance with the National Cancer Institute Common Terminology Criteria for Adverse Events v4.0. Multivariate-ordered logistic regression analysis was employed to examine the relationship between various predictive factors and the occurrence of PIPN.. Diabetes mellitus [odds ratio (OR)=0.070], age (OR=1.991), co-administration of neurotropin (OR=3.654), co-administration of opioids (OR=0.312), co-administration of vitamin B12 (OR=2.554), co-administration of antidepressant (OR=4.754) and co-administration of gabapentinoids (OR=14.620), were significantly associated with reduction of or less serious PIPN.. Our study indicates that PIPN may be alleviated by co-administration of opioids.

Topics: Aged; Analgesics, Opioid; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Female; gamma-Aminobutyric Acid; Genital Neoplasms, Female; Humans; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Pregabalin; Retrospective Studies